Issue 15, 2015

Stability indicating RP-HPLC method for the determination of flubendazole in pharmaceutical dosage forms

Abstract

This paper presents a stability study of the drug flubendazole (FLUB) – a benzimidazole carbamate derivative with anthelmintic activity. In order to investigate the stability of the drug, FLUB was subjected to stress degradation under different conditions, as recommended by the International Conference on Harmonization (ICH). A validated HPLC-photodiode array detector (DAD) method was established to resolve FLUB from all its degradation products obtained under acidic, basic, neutral, oxidation, photo-degradation, and thermal conditions, and also from its suspension additives. Chromatographic separation was achieved on a ZORBAX Eclipse Plus C18 column in an isocratic mode of elution using a mixture of water : acetonitrile (50 : 50, v/v) as a mobile phase, at a flow rate of 1 mL min−1, where FLUB was well resolved from all its degradation products at a tR of 5.35 min. The thermostated column compartment (TCC) was adjusted to 25 °C and the effluent was monitored by a photo-diode array detector at 254 nm, and FLUB was found to be linear in the range of 0.5–10 μg mL−1. The method was validated in terms of accuracy, precision, specificity, robustness, and ruggedness, as per USP guidelines. It was successfully applied to quantify FLUB in bulk powder and in pharmaceutical formulations with complete resolution between FLUB and its suspension additives. Statistical analyses between the suggested method and the official HPLC method using student's-t and F-ratio tests reveal that the suggested method is as accurate and precise as the reported one.

Graphical abstract: Stability indicating RP-HPLC method for the determination of flubendazole in pharmaceutical dosage forms

Article information

Article type
Paper
Submitted
03 Oct 2014
Accepted
15 Dec 2014
First published
15 Dec 2014

RSC Adv., 2015,5, 10927-10935

Author version available

Stability indicating RP-HPLC method for the determination of flubendazole in pharmaceutical dosage forms

N. S. Abdelwahab and M. M. Abdelrahman, RSC Adv., 2015, 5, 10927 DOI: 10.1039/C4RA11758A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements